​

Funding Round

Series E - Sutro Biopharma

Series E - Sutro Biopharma

Investment Firm

Overview

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

Announced Date

Jul 26, 2018

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

11

Investor Name
Participant InvestorCentene
Participant InvestorCelgene
Participant InvestorCitadel
Participant InvestorSV Health Investors
Participant InvestorSkyline Ventures

Round Details and Background

Sutro Biopharma raised $85400000 on 2018-07-26 in Series E

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2006
Series A - Sutro Biopharma
1-1.0M
Oct 16, 2007
Venture Round - Sutro Biopharma
2-305.0K
Dec 10, 2007
Series B - Sutro Biopharma
2-21.0M
Mar 30, 2009
Series B - Sutro Biopharma
2-15.0M

Recent Activity

There is no recent news or activity for this profile.